HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA $44 MIL. FY 1995 APPROPRIATIONS INCREASE

This article was originally published in The Rose Sheet

Executive Summary

FDA $44 MIL. FY 1995 APPROPRIATIONS INCREASE approved by the House Appropriations Committee on June 9 comes with a warning to the Clinton Administration about inflating proposals for user fees collections in future budges. In the report accompanying the bill, the committee noted that administration proposed to collect $252 mil. in "new user fees from regulated industries." However, the committee declared, in testimony before the committee on the proposal, Administration representatives from HHS and FDA could not "provide any information as to which regulated industries would pay user fees."

Latest Headlines
See All
UsernamePublicRestriction

Register

RS000537

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel